Investors bought shares of Johnson & Johnson (NYSE:JNJ) on weakness during trading on Thursday. $230.72 million flowed into the stock on the tick-up and $78.79 million flowed out of the stock on the tick-down, for a money net flow of $151.93 million into the stock. Of all companies tracked, Johnson & Johnson had the 6th highest net in-flow for the day. Johnson & Johnson traded down ($0.13) for the day and closed at $119.34

Several equities research analysts have issued reports on JNJ shares. Wells Fargo & Co. reiterated a “buy” rating on shares of Johnson & Johnson in a research note on Monday, June 6th. Deutsche Bank AG restated a “buy” rating on shares of Johnson & Johnson in a research note on Thursday, May 19th. Leerink Swann restated a “buy” rating on shares of Johnson & Johnson in a research note on Sunday, May 22nd. Zacks Investment Research upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 price objective on the stock in a research note on Friday, August 5th. Finally, Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $124.21 price objective on the stock in a research note on Monday, August 22nd. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and twelve have assigned a buy rating to the stock. Johnson & Johnson currently has a consensus rating of “Hold” and an average price target of $119.53.

The company has a market capitalization of $325.79 billion and a price-to-earnings ratio of 22.19. The stock has a 50-day moving average price of $122.54 and a 200-day moving average price of $114.81.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.68 by $0.06. The company had revenue of $18.50 billion for the quarter, compared to analysts’ expectations of $17.98 billion. On average, equities analysts anticipate that Johnson & Johnson will post $6.69 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 19th. Investors of record on Friday, August 5th were issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 0.97%.

In other news, CAO Ronald A. Kapusta sold 2,935 shares of Johnson & Johnson stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $125.01, for a total value of $366,904.35. Following the completion of the transaction, the chief accounting officer now owns 28,660 shares in the company, valued at $3,582,786.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ronald A. Kapusta sold 3,000 shares of Johnson & Johnson stock in a transaction dated Tuesday, June 7th. The stock was sold at an average price of $115.79, for a total transaction of $347,370.00. Following the completion of the transaction, the chief accounting officer now owns 28,725 shares of the company’s stock, valued at approximately $3,326,067.75. The disclosure for this sale can be found here.

Other institutional investors have bought and sold shares of the company. Marco Investment Management LLC increased its position in Johnson & Johnson by 2.3% in the fourth quarter. Marco Investment Management LLC now owns 48,052 shares of the company’s stock valued at $4,936,000 after buying an additional 1,100 shares during the last quarter. West Chester Capital Advisors Inc. increased its position in Johnson & Johnson by 12.6% in the fourth quarter. West Chester Capital Advisors Inc. now owns 17,746 shares of the company’s stock valued at $1,804,000 after buying an additional 1,984 shares during the last quarter. South Texas Money Management Ltd. increased its position in Johnson & Johnson by 9.4% in the fourth quarter. South Texas Money Management Ltd. now owns 17,265 shares of the company’s stock valued at $1,773,000 after buying an additional 1,478 shares during the last quarter. Venturi Wealth Management LLC acquired a new position in Johnson & Johnson during the fourth quarter valued at $2,920,000. Finally, Mutual of America Capital Management LLC increased its position in Johnson & Johnson by 0.4% in the fourth quarter. Mutual of America Capital Management LLC now owns 308,432 shares of the company’s stock valued at $31,682,000 after buying an additional 1,268 shares during the last quarter.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.